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scan was taken in normal mode. Registration with the planning CT was 
performed using automatic bone algorithm supervised by experienced 
medical staff which was instructed to evaluate not only the bony 
structures and body contour but also the position of arms, breast, 
lungs,heart, neck and spine. To evaluate the impact of thermoplastic 
mask in the overall treatment delivery we analysed MVCT shift data 
and MVCT dose distribution using Tomotherapy Planned Adaptive. 
Statistical analysis included significance tests (Mann-Whitney and 
variance χ2). Tests with p-values > 0.05 were scored as not significant 
(NS). 
MVCT shift data 
For all patients the shifts in left-right (LAT), superior-inferior (LONG), 
anterior-posterior (VERT) and axial (ROLL) rotation were recorded for 
each fraction. The population of the two groups were compared in 
terms of mean shift (systematic error) and its SD (random error). 
MVCT dose distribution 
For each patient a single fraction was selected at the middle of the 
whole treatment. Targets and ORs (spinal cord and heart for left-sided 
disease) were re-contoured on the MVCT using the treatment shift 
data. Target coverage and homogeneity was investigated in terms of 
V95% and D1% while ORs sparing was investigated interms of D1%. 
Results: 
Figure shows the distribution of the shift data for the two groups. 
 
  
The difference in absolute shift values between the two groups is NS. 
VERT shift variance is significantly reduced in the mask group 
compared to the WB group (see Table) but mean systematic error is 
always greater in the WB+O group. 
 
 In both groups target coverage (V95) and maximum dose (D1) is almost 
identical to planned values. D1 of ORs is not significantly different in 
the two groups.  
Conclusions: Van Herk’s margin is quite large in both groups. Analysis 
of shift data shows no improvement in the group of patients 
immobilized with thermoplastic mask: rather the mean systematic 
error is always greater. In both groups adapted dose distribution 
complies well with the planned one showing that if MVCT is used 
before each treatment fraction a 3 mm could be adequate. 
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Purpose/Objective: In many lung cancer patients anatomical changes 
may be observed during the radiotherapy treatment course. The 
purpose of this study is to determine the frequency of these changes. 
Materials and Methods: CBCT scans from 41 consecutive lung cancer 
patients treated from January 2010 to July 2010 were visually 
inspected to observe changes in tumour and normal tissue volume. 
The patients were treated with concomitant chemo-radiotherapy. The 
CBCT scans were inspected for fraction number 1, 6, 11, 16, 21, 26 
and 30/33. Differences in tumour size were registered. Likewise, 
disappearance or arise of atelectasis, pleural fluid or 
pneumonia/pneumonitis were noted. Furthermore, deviations, 
denoted Dev, equal to or larger than 1 cm were scored for tissue in 
the mediastinum and at the chest wall. The full CBCT scan (16 cm in 
craniocaudal direction) was evaluated independent of tumour 
position. 
Results: 24 of the patients showed tumour shrinkage. In 3 of the 
patients the tumour disappeared during the treatment course. 4 of 
the patients showed shrinkage of the lymphnodes. 4 patients had an 
atelectasis at the CT scan. 3 of these disappeared during the 
treatment course. In 3 patients an atelectasis appeared during the 
treatment course. 2 of these disappeared before fraction number 16. 
1 patient had a pneumonia/pneumonitis. 3 patients had pleural 
effusion. 4 patients had a rescan during the treatment course. 27 
patients had Dev ≥ 1 cm for tissue in the mediastinum not including 
the heart observed for at least 1 fraction. 11 of these deviations were 
persistent, i.e.seen for at least 3 consecutive inspected fractions. 25 
patients had Dev ≥ to 1 cm at the position of the heart and for 11 
patients the changes were persistent (3 of 41 patients did not include 
the heart in the CBCT). 10 patients had Dev ≥ to 1 cm at the chest 
wall. However, 5 of these did not receive 4D CT scan. Of these, 2 
patients had persistent deviations. 
Conclusions: Large changes were observed for lung cancer patients 
during their treatment course. Frequent analysis of the CBCT scans is 
a useful tool for evaluation of anatomic changes of the patient. The 
observations may be used to determine the necessity of an adaptive 
treatment plan for the individual patients. 
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Purpose/Objective: Head and Neck cancer (HNC) patients may 
undergo significant anatomic changes over the course of a radiation 
treatment. This event may be responsible for geographical miss of the 
tumor (TV) and/or for unnecessary irradiation of organs at risk (OARs). 
The use of Smart Adapt (SA) (Varian Medical System, v.11) software 
may help to fasten estimate the volume changes. The present study 
aims are: (1) to determine the accuracy of SA for the adaptation of 
both TVs and OARs by comparison to manual delineation; (2) To 
evaluate the differences between planned, delivered and adaptive 
dose, taking into account the voxel tracking information. 
Materials and Methods: Five HNC patient treated with IMRT 
simultaneous integrated boost and daily IGRT by Helical Tomotherapy 
(HT) were retrospectively analyzed. For each patient, the planning 
(KVCT1) and a per-treatment kvCT (KVCT2) as well a HT-MVCT 
performed at the same day, were used. TVs and OARs were manually 
contoured on both KVCT1 and KVCT2 images. Using SA, two sets of 
automatic structures were created by deforming KVCT1 to the KVCT2 
and MVCT respectively. A comparison between manually and 
deformed structures was performed and the corresponding anatomical 
variations during treatment were reported. To evaluate the impact of 
anatomic modifications on dose distribution, the total dose actually 
delivered was calculated. HT sinogram was applied on the MVCT 
image in order to generate per-treatment dose map. A new treatment 
plan was generated on KVCT2. Using the free tools of DIRART and 
CERR software, we applied the deformation field find out by SA on the 
dose. We compared (1) the planned dose, (2) the dose actually 
delivered, (3) the adaptive dose after the replanning. 
Results: First, a comparison between the manually delineated 
structures on KVCT2 and deformed structures on KVCT2 and MVCT was 
performed. For GTVs, the Dice Index (DI) was 0.88±0.06 on KVCT2 and 
0.74±0.21 on MVCT. For parotid glands the observed DI was 0.83±0.01 
on KVCT2 and 0.79±0.02 on MVCT and for the spinal cord the DI was 
0.80±0.02 on KVCT2 and 0.59 ±0.09 on MVCT. The volume reduction 
(ΔV) and center of mass shift (CMS) of both OARs and TVs during the 
course of radiotherapy was reported comparing the volumes on KVCT1 
and KVCT2. A ΔV of -1,84±3,19 % and -20.22±4.36 % and a CMS of 
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0.43±0.13 cm and 0.47±0.16 cm were observed for the GTV and 
parotids respectively. 
The comparison between planned, delivered and adaptive dose has 
been summarized in Table 1.  
 
  
Conclusions: The results obtained using SA software are encouraging. 
The accuracy of SA, for different quality images (KVCT and MVCT), is 
good, allowing a saving in process time. Furthermore, the SA tool, 
combined with an in house software, could enable the estimation of 
the cumulative dose actually delivered to the patients due to 
anatomical changes. However, the not optimal quality of MVCT images 
could limit our observations, therefore further analysis are needed to 
confirm these preliminary results.  
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Purpose/Objective: In order to understand which dosimetric 
parameters could be chosen as predictive indexes for genitourinary 
complications of prostate treatment, this study asses the inter-
fraction bladder motion and investigates its impact on the Dose–
Volume and Dose-Surface Histograms (DVH - DSH). 
Materials and Methods: Eight prostate cancer patients treated with 
radical intent were unrolled. For each patients a Tomotherapy plan 
was generated prescribing 70 Gy (2.5 Gy/fr X 28fr) to the 95% of the 
PTV volume. To avoid a setup errors, for each fraction a pretreatment 
MVCT image was acquired and a rigid registration on anatomical 
matches between MVCT and planning CT was performed and validate 
by the physicians. On each registered MVCT, bladder was contoured 
(using ECLIPSE TPS, Varian Medical System, Palo Alto, CA) by a single 
observer and copied on the planning CT, in order to have for the same 
planning dose distribution 28 per-treatment plus one planning bladder 
contours for each patients. Bladder DVH and dose surface histogram 
(DSH) were then computed using a dedicated software (VODCA, 
MSS,Inc.). Per-treatment DVHs and DSHs (DVHt and DSHt) were 
compared with planned DVHs and DSHs respectively (DVHp and DSHp). 
The difference mean and the SD between these parameters, were 
calculated and considered for the analysis in term of percentage (%) 
and absolute volume/surface. The trend of the dose-surface factors, 
by the evaluation of relative surface that receive at least 72 Gy (S72), 
was studied. 
Results: Random variations of volume and DVHs due to variable filling 
content of the bladder were found; a trend to be more empty during 
therapy with respect to planning CT was also found: the mean value of 
the volume for the 28th fractions and planning CT are respectively 171 
cm3 and 233 cm3 (p<0.05), while the mean surface value are 204 cm2 
vs. 231cm2 (p=0.056). For the eight patients unrolled a more robust 
trend was observed for the DSH respect to DVH when are take in 
account the differences between the planning and per-treatment 
parameters as well those showed in Figure 1, where the standard 
deviations are represented as dashed lines. In three patients, an 
important reduction of the surface, in % values, receiving high doses 
was observed during the treatment (Figure 2). T-Student test showed 
an overall statistically significant reduction of S72 (DSHt– DSHp) with a 
mean difference equal to -1.5% of the total bladder surface (p=0.052). 
 
  
Conclusions: Despite the random variation of the bladder volume 
shape and position during the treatment, our preliminary results show 
that the DSH could be more robust than the DVH to be a predictive 
index for the bladder toxicity. The reduction of the surface value 
which receive high doses in three patients was probably related to the 
prostate edema induced by the treatment that causes a vertical shift 
of the bladder outside the high dose region. 
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Purpose/Objective: To take into account setup uncertainties and 
patient breathing, the intensity extension of IMRT treatment fields in 
the superficial parts of the body could be generated. This study 
investigates (i) the dosimetric impact of uncorrected setup errors on 
superficial breast doses in cases of the IMRT plans with and without 
intensity extension (IE), (ii) the sufficiency of the applicable fluence 
extension margin. 
Materials and Methods: 5-field IMRT plans with and without IE outside 
the breast contour were created for 10 consecutive patients. The 
fluence was extended outside the body up to 8mm in the anterolateral 
(AL) direction using the skin flash (SF) tool method applied in an 
Eclipse TPS. To evaluate sufficiency of the SF margin, the following 
structure in the superficial region (SR) 0-8 mm beneath the skin 
surface was created for the plans with IE and without IE. The 
displacement results of setup errors were obtained by 2D kV images 
and after applying the corrections the portal images were acquired for 
the two most external beams used to verify the sufficiency of the SF 
margin. According to the acquired setup errors, the isocenter was 
shifted in the treatment planning system to simulate uncorrected dose 
distributions. The evaluation of the displacement impact was 
performed based on DVH analyses of the SR, PTV doses and the 
internal target coverage (ITC) for PTV defined as (D5% – D95%)/D95% for 
plans with IE against plans without IE. 
Results: Using the SF method increased the average number of MU by 
15%, up to 158 MU. The AL vector displacement >5mm of up to 17mm 
occurred on 44/93 (47%) occasions. Table 1 presents the differences 
between the dosimetric values obtained for the SR, PTV and  ITC for 
the IMRT plans with and without IE as a consequence of the 
uncorrected setup errors. The AL vector displacement was divided 
into three subgroups depending on the influence of setup error on the 
analyzed values. Group systematic (and random) setup errors 
detected by portal images were 2.2 (3.2) mm laterally, 1.6 (4.0) mm 
vertically and the maximum displacement in the AL direction did not 
exceed 8mm. 
Table 1 presents the mean differences and standard deviations in 
percentage between the dosimetric values obtained for the breast 
IMRT plans with and without IE as a consequence of the uncorrected 
setup errors; Dmean=mean dose, Dmax=maximum dose. 
